Kenneth Hoberman

Affiliations

  • Director at Tg Therapeutics Inc. (TGTX), 2023-09-29
  • Director at Nuvectis Pharma Inc. (NVCT), 2023-06-20
  • Chief Operating Officer at Stemline Therapeutics Inc (STML), 2020-06-10
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NVCT $17.40 6,000 Director 55,140 2022-05-12 Filing
STML $10.99 2,000 Officer 89,535 2014-09-02 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
STML $4.91 16,704 Officer 771,764 2020-03-10 Filing
STML $5.08 9,487 Officer 788,468 2020-03-09 Filing
STML $6.42 11,547 Officer 797,955 2020-02-25 Filing
STML $7.02 22,139 Officer 601,085 2020-01-22 Filing
STML $10.37 13,228 Officer 623,224 2020-01-08 Filing